An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Clinical trial NCT06379646 · RECRUITING

Trial details

NCT number: NCT06379646
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Systemic Sclerosis Inflammatory Myopathy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Antiphospholipid Syndrome Sjogren's Syndrome

Start date: 2024-04-24
Primary completion: 2025-04-21
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.